China-based biotech Fapon Biotech Inc. has announced a partnership with China Resources Pharmaceutical Commercial Group Medical Device Co., Ltd to develop an in vitro diagnostics (IVD) open platform ecosystem. The collaboration aims to enhance the development and market presence of IVD solutions. Financial details of the partnership were not disclosed.
Company Profiles
Founded in 2001, Fapon Bio has established a global business presence covering Europe, America, Asia, Australia, and Africa. The company specializes in the development and marketing of IVD products and solutions. CR Pharma Comme Medical Device, established in 2017, markets Category I, II, and III medical devices. The company boasts over 30 independent device units in China and generated RMB 21.4 billion (USD 2.987 billion) in sales as of December 2021.
Future Implications
The partnership between Fapon Biotech and CR Pharma Comme Medical Device is expected to drive innovation in the IVD sector. By combining their expertise, the companies aim to develop a comprehensive open platform ecosystem that will enhance the accessibility and efficiency of diagnostic solutions. This collaboration underscores the commitment of both companies to advancing healthcare through innovative diagnostics.-Fineline Info & Tech
